The role of glycometabolic plasticity in cancer

Pathol Res Pract. 2021 Aug 25;226:153595. doi: 10.1016/j.prp.2021.153595. Online ahead of print.ABSTRACTDysregulated glycometabolism represented by the Warburg effect is well recognized as a hallmark of cancer that can be driven by oncogenes (e.g., c-Myc, K-ras, and BRAF) and contribute to cellular malignant transformation. The Warburg effect reveals the different glycometabolic patterns of cancer cells, but this unique glycometabolic pattern has the characteristic of plasticity rather than changeless which can vary with different internal or external stimuli during evolution. Glycometabolic plasticity enables cancer cells to modulate glycometabolism to support progression, metastasis, treatment resistance and recurrence. In this review, we report the characteristics of glycometabolic plasticity during different stages of cancer evolution, providing insight into the molecular mechanisms of glycometabolic plasticity in cancer. In addition, we discussed the challenges and future research directions of glycometabolism research in cancer.PMID:34481210 | DOI:10.1016/j.prp.2021.153595
Source: Pathology, Research and Practice - Category: Pathology Authors: Source Type: research